Hans-Juergen Krause

This inventor holds 32 USPTO granted patents and 12 published patent applications, plus 7 CIPO patents and 3 EPO patents, primarily in Protein Formulations. Top assignees: Abbvie Biotechnology Ltd, Abbvie Inc., Abbott Biotechnology Ltd.. Active years: 2011-2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hans-Juergen Krause. Retrieved from https://idiyas.com/inventor/hans-juergen-krause

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 32 (Patent Applications = 12)

% Patents Active = 56.3

CIPO Patents = 7 (Patent Applications = 8)

EPO Patents = 3 (Patent Applications = 7)

Average Co-Inventor Count = 3.5

ph-index = 16

Forward Citations = 825(Granted Patents)

Location History:

Gruenstadt, DE (2011 - 2018)
Biblis, DE (2013 - 2021)

Company Filing History:

26 out of 93

Abbvie Biotechnology Ltd

Abbott Biotechnology Ltd.

patents

4. 1 out of 4,188

Abbott Laboratories Corporation

patents

5. 1 out of 167

Abbvie Deutschland Gmbh and Co Kg

patents

Years Active: 2011-2021

Loading Chart...

Areas of Expertise:

Protein Formulations

Human Antibodies

TNF-alpha Disorders

Anti-TNF Antibody

Crystalline Antibodies

Powdered Protein

Therapeutic Applications

Formulation Methods

32 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11191834 - Protein formulations and methods of making same (2021-12-07),

2. 11167030 - Protein formulations and methods of making same (2021-11-09),

3. 9950066 - Formulation of human antibodies for treating TNF-alpha associated disorders (2018-04-24),

4. 9750808 - Formulation of human antibodies for treating TNF-alpha associated disorders (2017-09-05),

5. 9738714 - Formulation of human antibodies for treating TNF-alpha associated disorders (2017-08-22),

6. 9732152 - Formulation of human antibodies for treating TNF-alpha associated disorders (2017-08-15),

7. 9610301 - Powdered protein compositions and methods of making same (2017-04-04),

8. 9327032 - Formulation of human antibodies for treating TNF-alpha associated disorders (2016-05-03),

9. 9302011 - Formulation of human antibodies for treating TNF-α associated disorders (2016-04-05),

10. 9295725 - Formulation of human antibodies for treating TNF-alpha associated disorders (2016-03-29),

11. 9289497 - Formulation of human antibodies for treating TNF-alpha associated disorders (2016-03-22),

12. 9272042 - Formulation of human antibodies for treating TNF-alpha associated disorders (2016-03-01),

13. 9272041 - Formulation of human antibodies for treating TNF-alpha associated disorders (2016-03-01),

14. 9220781 - Formulation of human antibodies for treating TNF-alpha associated disorders (2015-12-29),

15. 9114166 - Formulation of human antibodies for treating TNF-α associated disorders (2015-08-25),

Title: The Innovative Journey of Hans-Juergen Krause

Introduction:

Hans-Juergen Krause is a renowned inventor hailing from Gruenstadt, Germany. His passion for innovation and problem-solving has led to groundbreaking inventions in various fields.

Latest Patents:

Hans-Juergen Krause holds several patents in the areas of renewable energy, automotive technology, and medical devices. His recent patents focus on sustainable energy solutions and cutting-edge advancements in the automotive industry.

Career Highlights:

Throughout his career, Hans-Juergen Krause has worked with leading research institutions and companies to bring his inventions to life. His dedication to pushing the boundaries of technology has earned him recognition as a pioneer in his field.

Collaborations:

Hans-Juergen Krause has collaborated with top engineers, scientists, and designers to develop innovative solutions to complex challenges. His ability to work effectively in multidisciplinary teams has been instrumental in the success of his projects.

Conclusion:

In conclusion, Hans-Juergen Krause's relentless pursuit of innovation and his commitment to excellence have established him as a prominent figure in the world of inventors. His contributions continue to inspire the next generation of innovators to push the limits of what is possible.

Profile summary based on public USPTO records.